Patent US6551255B2 successfully refreshed from Google Patents.
← Back to Patent Explorer
US4852579A Expired / Lapsed US ⏱️ 0.0 years remaining

Photocharacterization and treatment of normal abnormal and ectopic endometrium

Assignee: STORZ ENDOSCOPY AND Co GmbH
•
Filing: 1987-04-20
•
Granted: 1989-08-01
•
Expires: 2007-04-20
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method and apparatus for optical diagnosis and treatment of abnormal cells through the use of hormone-specific chemical markers which are preferential to genital tissues. Abnormal cells can be differentiated from normal cells by the amount of fluorescent or thermal radiation produced by the chemical marker retained in the respective cells when irradiated with electromagnetic radiation at a predetermined wavelength. Once the abnormal cells have been detected, they can be treated through the use of an optical technique based on photochemical or thermal reactions which can be controlled to destroy the abnormal cells, while leaving normal cells unharmed.

Inventors

  • 👤 Dennis W. Gilstad
  • 👤 Ronald L. Branstetter
  • 👤 Ralph H. Hill, Jr.

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 13:07
CPC Classifications
A; A61; A61B; A61B10/00

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 69 words
A method of photocharacterization of tissue, comprising the steps of: injecting said patient with a hormone-specific chemical marker, said chemical marker being preferential to genital tissue; illuminating a portion of said tissue with an optical excitation means producing light having a predetermined wavelength; and detecting fluorescent radiation produced by said portion of tissue; and correlating said fluorescent radiation with the existence of abnormal cells in said portion of tissue.
Claim 2
Independent Claim 69 words
A method of photocharacterization of tissue, comprising the steps of: injecting said patient with a hormone-specific chemical marker, said chemical marker being preferential to genital tissue; illuminating a portion of said tissue with an optical excitation means producing light having a predetermined wavelength; and detecting fluorescent radiation produced by said portion of tissue; and correlating said fluorescent radiation with the existence of abnormal cells in said portion of tissue.
Claim 3
Dependent Claim 42 words
The method according to claim 1, wherein said optical excitation means further comprises an optical delivery guide means for selectively radiating said portion of tissue with said light and an optical return guide means for collecting fluorescent radiation produced by said tissue.
Claim 4
Dependent Claim 19 words
The method according to claim 2, said optical delivery means and said optical return guide means comprising an endoscope.
Claim 5
Dependent Claim 13 words
The method according to claim 3, said optical excitation means comprising a laser.
Claim 6
Dependent Claim 15 words
The method according to claim 4, said chemical marker being preferential to the genital tissues.
Claim 7
Dependent Claim 21 words
The method according to claim 5, said chemical marker being chosen from the group consisting of tamoxifen citrate, clomiphene, and danazol.
Claim 8
Independent Claim 146 words
A method for photocharacterization of tissue wherein said tissue has absorbed a hormone-specific chemical marker, comprising the steps of: irradiating a portion of said tissue with a source of laser light having a predetermined wavelength; irradiating said portion of said tissue with conventional light; detecting fluorescent radiation produced by said tissue in response to said laser light; processing said fluorescent radiation to obtain a first image at a first intensity; detecting light reflected by said portion of tissue in response to said conventional light; processing said reflected light to obtain a second image at a second intensity; amplifying said first image at said first intensity to obtain a first image having approximately the same intensity as said second image; combining said first and second images to obtain a composite image; and correlating said composite image with the existence of abnormal cells in said portion of tissue.
Claim 9
Independent Claim 146 words
A method for photocharacterization of tissue wherein said tissue has absorbed a hormone-specific chemical marker, comprising the steps of: irradiating a portion of said tissue with a source of laser light having a predetermined wavelength; irradiating said portion of said tissue with conventional light; detecting fluorescent radiation produced by said tissue in response to said laser light; processing said fluorescent radiation to obtain a first image at a first intensity; detecting light reflected by said portion of tissue in response to said conventional light; processing said reflected light to obtain a second image at a second intensity; amplifying said first image at said first intensity to obtain a first image having approximately the same intensity as said second image; combining said first and second images to obtain a composite image; and correlating said composite image with the existence of abnormal cells in said portion of tissue.
Claim 10
Dependent Claim 28 words
The method according to claim 7, said step of correlating said composite image further comprising the step of projecting said first and second images on a video screen.
Claim 11
Dependent Claim 15 words
The apparatus according to claim 8, said chemical marker being preferential to the genital tissues.
Claim 12
Dependent Claim 21 words
The method according to claim 9, said chemical marker being chosen from the group consisting of tamoxifen citrate, clomiphene, and danazol.

References Cited (Backward Citations)

GB2126717A Cited
US4675529A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-07-31 1993-01-30 1993-08-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-07-31 1997-01-30 1997-08-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-07-31 2001-01-30 2001-08-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag